Xeris Biopharma

XERSNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.604 B

$8.80 +7.32%

Close of 21 Sept 2026

Revenue

$291.8M

#2140 by revenue

Earnings

$554.0K

#2403 by earnings

Shares outstanding

182,320,306

Latest filing cover page

P/E ratio

2896.1

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#123AnaptysbioANAB$1.63B
#124Syndax PharmaceuticalsSNDX$1.61B
#125Xeris BiopharmaXERS$1.60B
#126Eton PharmaceuticalsETON$1.58B
#127Kailera TherapeuticsKLRA$1.55B

What if Xeris Biopharma were worth as much as…

Open the what-if tool →

Gold $30.3T

$166,048.72

Per share 18,869× higher

Bitcoin $1.72T

$9,432.87

Per share 1,072× higher

Nvidia $5.48T

$30,056.21

Per share 3,415× higher

Or at a round number

$2.00B $5.00B $10.0B $20.0B

Where these numbers come from

Share counts and financials for Xeris Biopharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.